12:00 AM
 | 
Apr 01, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Metreleptin regulatory update

Shionogi said Japan approved an NDA for metreleptin to treat lipodystrophy. Shionogi licensed the product from Amylin Pharmaceuticals Inc., which Bristol-Myers acquired. Amylin had rights to...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >